CN106389784A - 清肺润肺、增强免疫力的组合物及其应用 - Google Patents
清肺润肺、增强免疫力的组合物及其应用 Download PDFInfo
- Publication number
- CN106389784A CN106389784A CN201610814988.4A CN201610814988A CN106389784A CN 106389784 A CN106389784 A CN 106389784A CN 201610814988 A CN201610814988 A CN 201610814988A CN 106389784 A CN106389784 A CN 106389784A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- enhancing immunity
- compositionss
- heat clearing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004072 lung Anatomy 0.000 title claims abstract description 98
- 230000036039 immunity Effects 0.000 title claims abstract description 48
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 155
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 32
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 32
- 239000006041 probiotic Substances 0.000 claims abstract description 30
- 235000018291 probiotics Nutrition 0.000 claims abstract description 30
- 230000000529 probiotic effect Effects 0.000 claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 20
- 241000233779 Cyclocarya paliurus Species 0.000 claims abstract description 20
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 20
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 20
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 20
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 17
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 17
- 235000008434 ginseng Nutrition 0.000 claims abstract description 17
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 15
- 241000287420 Pyrus x nivalis Species 0.000 claims abstract description 14
- 235000015206 pear juice Nutrition 0.000 claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 9
- 235000013305 food Nutrition 0.000 claims abstract description 8
- 235000012055 fruits and vegetables Nutrition 0.000 claims abstract description 3
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 5
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 3
- 210000000582 semen Anatomy 0.000 claims description 31
- 241000894006 Bacteria Species 0.000 claims description 30
- 235000012054 meals Nutrition 0.000 claims description 29
- 239000000835 fiber Substances 0.000 claims description 23
- 241000239366 Euphausiacea Species 0.000 claims description 18
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 17
- 244000144927 Aloe barbadensis Species 0.000 claims description 16
- 235000005593 Camellia sinensis f parvifolia Nutrition 0.000 claims description 16
- 244000041840 Camellia sinensis f. parvifolia Species 0.000 claims description 16
- 241000233866 Fungi Species 0.000 claims description 16
- 240000006240 Linum usitatissimum Species 0.000 claims description 16
- 235000004431 Linum usitatissimum Nutrition 0.000 claims description 16
- 235000004426 flaxseed Nutrition 0.000 claims description 16
- 241000628997 Flos Species 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 6
- 235000013339 cereals Nutrition 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 3
- 229930003451 Vitamin B1 Natural products 0.000 claims description 3
- 229930003779 Vitamin B12 Natural products 0.000 claims description 3
- 229930003471 Vitamin B2 Natural products 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 3
- 238000013329 compounding Methods 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 3
- 229960002477 riboflavin Drugs 0.000 claims description 3
- 229960003495 thiamine Drugs 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 3
- 235000010374 vitamin B1 Nutrition 0.000 claims description 3
- 239000011691 vitamin B1 Substances 0.000 claims description 3
- 235000019163 vitamin B12 Nutrition 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- 235000019164 vitamin B2 Nutrition 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- 235000019158 vitamin B6 Nutrition 0.000 claims description 3
- 239000011726 vitamin B6 Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 3
- 235000005282 vitamin D3 Nutrition 0.000 claims description 3
- 239000011647 vitamin D3 Substances 0.000 claims description 3
- 229940011671 vitamin b6 Drugs 0.000 claims description 3
- 229940021056 vitamin d3 Drugs 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 2
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 2
- 241000186012 Bifidobacterium breve Species 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 2
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 2
- 241000186866 Lactobacillus thermophilus Species 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 2
- -1 pollen Substances 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 235000013406 prebiotics Nutrition 0.000 claims 2
- 244000099147 Ananas comosus Species 0.000 claims 1
- 235000007119 Ananas comosus Nutrition 0.000 claims 1
- 244000000626 Daucus carota Species 0.000 claims 1
- 235000002767 Daucus carota Nutrition 0.000 claims 1
- 240000008790 Musa x paradisiaca Species 0.000 claims 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000013376 functional food Nutrition 0.000 abstract description 11
- 244000061508 Eriobotrya japonica Species 0.000 abstract description 3
- 235000009008 Eriobotrya japonica Nutrition 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 abstract 1
- 244000028550 Auricularia auricula Species 0.000 abstract 1
- 235000000023 Auricularia auricula Nutrition 0.000 abstract 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 1
- 235000009815 Momordica Nutrition 0.000 abstract 1
- 241000218984 Momordica Species 0.000 abstract 1
- 241001412231 Scaphium <angiosperm> Species 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 241000218628 Ginkgo Species 0.000 description 27
- 230000000694 effects Effects 0.000 description 23
- 239000007788 liquid Substances 0.000 description 15
- 241000208340 Araliaceae Species 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 241000700159 Rattus Species 0.000 description 9
- 230000006870 function Effects 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 210000002345 respiratory system Anatomy 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 231100000357 carcinogen Toxicity 0.000 description 5
- 239000003183 carcinogenic agent Substances 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000002685 pulmonary effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 230000009545 invasion Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 240000005001 Paeonia suffruticosa Species 0.000 description 3
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- YXHVCZZLWZYHSA-UHFFFAOYSA-N (Z)-6-[8-pentadecenyl]salicylic acid Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- TUGAUFMQYWZJAB-FPLPWBNLSA-N 5-[(8Z)-pentadec-8-enyl]resorcinol Chemical compound CCCCCC\C=C/CCCCCCCC1=CC(O)=CC(O)=C1 TUGAUFMQYWZJAB-FPLPWBNLSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000230106 Aloe perryi Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- SRLTUZDQBFYLQI-FPLPWBNLSA-N Bilobol Natural products Oc1c(CCCCCCC/C=C\CCCCCC)ccc(O)c1 SRLTUZDQBFYLQI-FPLPWBNLSA-N 0.000 description 1
- 241000050051 Chelone glabra Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- YXHVCZZLWZYHSA-FPLPWBNLSA-N Ginkgoic acid Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1C(O)=O YXHVCZZLWZYHSA-FPLPWBNLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010021079 Hypopnoea Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000567 combustion gas Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000550 effect on aging Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000006450 immune cell response Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明提供了一种清肺润肺、增强免疫力的组合物及其应用,属于医药或食品领域。该功能性食品的原料按重量份数计包括:益生菌酵素1800~2500份、亚麻籽粉3~10份、雨生红球藻粉1~7份、茶籽粉1~7份、库拉索芦荟粉1~7份、蘑菇粉1~7份、黑木耳粉1~7份、青钱柳叶1~7份、果蔬纤维素10~20份、枸杞1~7份、人参1~7份、大枣1~7份、玛卡粉1~7份、低聚果糖2~3份、白果叶粉1~7份、雪梨汁10~20份、枇杷10~20份、枇杷叶1~7份、枇杷树皮1~7份、罗汉果1~7份和胖大海1~7份。该功能性食品能够起到提高人体免疫力、清肺益气。此外,本发明还涉及此组合物的应用。
Description
技术领域
本发明涉及医药或食品领域,具体而言,涉及一种清肺润肺、增强免疫力的组合物及其应用。
背景技术
近年来,由于灰霾、油烟、汽车尾气、香烟燃烧气体等的加剧,肺气虚证发生率有逐年上升的趋势。肺气虚证,相当于西医学中的肺系疾病。渐进性、持续性的肺脏功能损伤,导致呼吸系统免疫力逐步下降,气管黏膜萎缩,肺泡数量减少,肺纤维化增多,进而累及多系统、多脏器功能障碍,后果严重,预后不佳。
发明内容
本发明的目的在于提供一种清肺润肺、增强免疫力的组合物,其能增强人体免疫力,同时清肺润肺、排除身体毒素,对雾霾、汽车尾气、苯并芘等强致癌物对呼吸道和肺部的侵袭有较好的预防和治疗作用。
本发明的另一目的在于提供一种清肺润肺、增强免疫力的组合物在制备清肺润肺、增强免疫力的药物中的应用。
本发明的另一目的在于提供一种一种清肺润肺、增强免疫力的组合物在制备清肺润肺、增强免疫力的食品中的应用。
本发明解决其技术问题是采用以下技术方案来实现的。
一种清肺润肺、增强免疫力的组合物,其原料按重量份数计包括:益生菌酵素1800~2500份、亚麻籽粉3~10份、雨生红球藻粉1~7份、茶籽粉1~7份、库拉索芦荟粉1~7份、蘑菇粉1~7份、黑木耳粉1~7份、青钱柳叶1~7份、果蔬纤维素10~20份、枸杞1~7份、人参1~7份、大枣1~7份、玛卡粉1~7份、低聚果糖2~3份、白果叶粉1~7份、雪梨汁10~20份、枇杷10~20份、枇杷叶1~7份、枇杷树皮1~7份、罗汉果1~7份和胖大海1~7份。
一种清肺润肺、增强免疫力的组合物在制备清肺润肺、增强免疫力药物中的应用。
一种清肺润肺、增强免疫力的组合物在制备清肺润肺、增强免疫力食品中的应用。
本发明提供的一种清肺润肺、增强免疫力的组合物及其应用的有益效果是:本发明以益生菌酵素为基础成分,并添加亚麻籽粉、牡丹籽粉、磷虾粉、DHA藻油、白果粉、雨生红球藻粉、茶籽粉、库拉索芦荟粉、蘑菇粉、黑木耳粉、青钱柳叶、果蔬纤维素、枸杞、人参、大枣、玛卡粉、低聚果糖。能够起到提高人体免疫力、滋润强壮、清肺益气、补血活血、解毒消肿等功效。通过加强身体的抗氧化能力,从而减缓人体衰老的速度,并且针对雾霾、汽车尾气、苯并芘等强致癌物对呼吸道和肺部的侵袭有极大的改善,能够有效的预防癌症的产生。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将对本发明实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
下面对本发明实施例的一种清肺润肺、增强免疫力的组合物及其应用进行具体说明。
一种清肺润肺、增强免疫力的组合物,其原料按重量份数计包括:益生菌酵素1800~2500份、亚麻籽粉3~10份、雨生红球藻粉1~7份、茶籽粉1~7份、库拉索芦荟粉1~7份、蘑菇粉1~7份、黑木耳粉1~7份、青钱柳叶1~7份、果蔬纤维素10~20份、枸杞1~7份、人参1~7份、大枣1~7份、玛卡粉1~7份、低聚果糖2~3份、白果叶粉1~7份、雪梨汁10~20份、枇杷10~20份、枇杷叶1~7份、枇杷树皮1~7份、罗汉果1~7份和胖大海1~7份。
在本发明的较佳实施例中,按重量份数计,上述益生菌酵素2000份、亚麻籽粉5~7份、雨生红球藻粉3~5份、茶籽粉3~5份、库拉索芦荟粉3~5份、蘑菇粉3~5份、黑木耳粉3~5份、青钱柳叶3~5份、果蔬纤维素10~15份、枸杞2~5份、人参2~5份、大枣3~5份、玛卡粉3~5份、低聚果糖2~3份、白果叶粉3~5份、雪梨汁10~15份、枇杷10~15份、枇杷叶3~5份、枇杷树皮3~5份、罗汉果3~5份和胖大海3~5份。
益生菌酵素是有多种益生菌发酵而成的制品。益生菌酵素可以促进人体的新陈代谢,分解血液中的胆固醇和高血脂蛋白,能有效减低血清胆固醇水平;分解血管内与血管壁内沉积的脂肪,使血液流通,血管弹性修复,减低血压和血脂水平;促进细胞再生,使机体产生更多的胰岛素,减低血糖水平。
具体地,益生菌酵素主要由复配益生菌在益生菌培养基上培养发酵制得,按重量份数计,复配益生菌包括:青春双歧杆菌20~100份、嗜酸乳杆菌20~100份、嗜热乳杆菌20~100份、短双歧杆菌20~100份、双歧杆菌20~100份、植物乳杆菌20~100份。
益生菌培养基包括:菌类多糖、藻类多糖、植物粉、花粉、水果、蔬菜和五谷。
当纯净水温度达到35~37度时用益生菌接种,培养发酵时间为24~168小时,形成基础酵素液或在基础酵素液的基础上添加低聚果糖、抗性糊精、低聚麦芽糖、低聚木糖、胶原蛋白、大豆分离蛋白调配制粒,低温干燥制备成酵素颗粒,用于配制多种具有指向性功能性食品、保健食品、药品的天然活性原料。
该基础酵素液或酵素颗粒均可作为本发明实施例中的益生菌酵素,采用上述原料制得的益生菌酵素含有多种天然活性成分,本发明实施例以益生菌酵素为基础成分,并添加亚麻籽粉、牡丹籽粉、磷虾粉、DHA藻油、白果粉、雨生红球藻粉、茶籽粉、库拉索芦荟粉、蘑菇粉、黑木耳粉、青钱柳叶、果蔬纤维素、枸杞、人参、大枣、玛卡粉、低聚果糖。能够起到提高人体免疫力、滋润强壮、清肺益气、补血活血、解毒消肿等功效。
亚麻籽粉的木脂素会在肠道里被细菌转变成可以对抗癌症的物质,同时α~亚麻油酸可以增强免疫细胞反应,促进我们的免疫系统,减少体内的发炎现象。亚麻籽含有温和的植物雌激素,可以对抗体内过多的雌激素,它具有抗癌效果。同时亚麻籽粉包含一些天然的抗氧化剂,因此能帮助疲乏的肌肉更快复原。此外,它的抗炎功效还能帮助减轻肌肉酸痛。
雨生红球藻粉是由雨生红球藻研磨成分制得的,雨生红球藻具有较强的抗氧化作用,抗氧化、消除自由基方面的能力均强于β类胡萝卜素,可以促进抗体的产生、增强免疫功能。
库拉索芦荟粉具有防止细胞老化和治疗慢性过敏的作用,同时让组织富有弹性,增强防御能力,其能够提高免疫力和抑制、破坏异常细胞的生长的作用,从而达到抗癌目的。同时库拉索芦荟粉还具有抗病毒感染,促进伤口愈合复原的作用。
而蘑菇粉、黑木耳粉、青钱柳叶、果蔬纤维素、枸杞、人参、大枣和玛卡粉均能够提高机体免疫力,同时还能滋润强壮、清肺益气、补血活血、解毒消肿等功效。
同时,青钱柳叶、玛卡粉和茶籽粉还具有抗氧化和抗衰老的功效,能够增强身体的抗氧化能力,并且大枣和低聚果糖具有一定的抗癌作用,青钱柳叶、玛卡粉、大枣和低聚果糖四者的相互配合,不仅仅加强了身体的抗氧化能力,从而减缓人体衰老的速度,并且针对雾霾、汽车尾气、苯并芘等强致癌物对呼吸道和肺部的侵袭有极大的改善,能够有效的预防癌症的产生。
将牡丹籽粉、磷虾粉、DHA藻油和白果粉添加至益生菌酵素中,能够在益生菌酵素的基础上,改善大脑功能、提神醒脑,从而起到益智健脑的作用,配合亚麻籽粉、雨生红球藻粉、库拉索芦荟粉、蘑菇粉、黑木耳粉、青钱柳叶、果蔬纤维素、枸杞、人参、大枣和玛卡粉等具有提高机体免疫力功效的原料,在提高人体免疫力的基础上,还能起到滋润强壮、清肺益气、补血活血、解毒消肿等功效,并且青钱柳叶、玛卡粉和茶籽粉还具有抗氧化和抗衰老的功效,能够增强身体的抗氧化能力,从而减缓人体衰老的速度。
白果叶粉有一定的降压作用,润肺,喘咳痰嗽,而枇杷、枇杷叶、枇杷树皮、罗汉果和胖大海均能够清肺胃热、降气化痰、润肠通便,同时还能起到抗菌作用。
雪梨汁具生津润燥、清热化痰之功效,能润肺、消痰、降火、解毒。因此对急性气管炎和上呼吸道感染的患者出现的咽喉干、痒、痛、音哑、痰稠、便秘、尿赤均有良效。尤其适用于时常吸入雾霾和汽车尾气的人群使用,能够起到清肺、润肺、消痰、解毒的作用。
将白果叶粉、雪梨汁、枇杷、枇杷叶、枇杷树皮、罗汉果和胖大海与上述的亚麻籽粉、雨生红球藻粉、茶籽粉、库拉索芦荟粉、蘑菇粉、黑木耳粉、青钱柳叶、果蔬纤维素、枸杞、人参、大枣、玛卡粉和低聚果糖配合,不仅仅加强了机体免疫力,同时还加强了清肺润肺、降气化痰的作用,并且还能抗癌。
在本发明的较佳实施例中,按重量份数计,原料还包括牡丹籽粉1~7份、磷虾粉1~7份、DHA藻油1~7份、白果粉1~7份。
优选地,上述牡丹籽粉为3~5份、磷虾粉为3~5份、DHA藻油为3~5份、白果粉为3~5份。
具体地,牡丹种子是受果壳和种壳双层保护的坚果,具有天然的“长寿”基因,牡丹籽粉是由牡丹籽研磨成粉制成,其含有超过40%的亚麻酸,亚麻酸能够增强自身免疫、防治癌症、清理血中有害物质和防治心脏病、提神健脑,增强注意力和记忆力。牡丹籽粉的增强自身免疫的功能,使人体能够抵制雾霾和汽车尾气苯并芘等强致癌物对呼吸道和肺部的侵袭,同时牡丹籽粉还能预防癌症,进一步保护人们身体健康。
磷虾具有抗老化性能。磷虾含有人体必需的7种氨基酸和2种半必需氨基酸,可以改善皮肤组织,增强全身的免疫系统。磷虾含有高质量的胆碱,可以促进婴儿和儿童的大脑发育。因而利用磷虾研磨制成的磷虾粉能够有效的增强人体的免疫系统,从而使人体能够抵制雾霾和汽车尾气苯并芘等强致癌物对呼吸道和肺部的侵袭,保护人们身体健康。
DHA藻油能够增强记忆与思维能力、提高智力等作用更为显著。起到益智健脑的作用。
白果粉是白果研磨成粉制得的,白果中含有的白果酸、白果酚,能够抑菌和杀菌作用,可用于治疗呼吸道感染性疾病。此外,白果具有排毒养颜、祛痘之功效,可以滋阴养颜抗衰老,扩张微血管、促进血液循环,使人肌肤红润,精神焕发,延年益寿。白果还具有通畅血管、改善大脑功能、增强记忆能力、治疗老年痴呆症和脑供血不足等功效。将牡丹籽粉、磷虾粉、DHA藻油和白果粉混合,加强了该功能性食品的益智健脑的作用。
进一步地,在本发明的较佳实施例中,原料还包括维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D3。这些维生素能够补充人体所需的微量元素,从而提高人体的健康状态。
本发明提供的组合物具有很好的清肺润肺、增强免疫力的功效,可以用于在制备清肺润肺、增强免疫力的药物中的应用。制备得到的药物可以为口服液、片剂、胶囊剂、粉剂、颗粒剂或固体冲剂等。
本发明提供的组合物具有很好的清肺润肺、增强免疫力的功效,可以用于在制备清肺润肺、增强免疫力的食品中的应用。制备得到的食品具有很好的保健功效,可以为饮品、凝胶糖果或酒等。
本发明的功能性食品,不受生产加工剂型的限制。可以按从那些为了快速释放其有效成分,并持续较长时间的技术中的常规方法中获知的配方制造。
当该功能性食品为口服液或饮品时:每天服用1~2次,每次服用50ml~100ml。
当该功能性食品为片剂、胶囊或凝胶糖果时:每天服用2次,每次服用2片(粒/块),每片(粒/块)500mg~2000mg。
当该功能性食品为粉剂、颗粒剂或固体冲剂时:每天服用1~2次,每次10g~30g。
当该功能性食品为酒时:每天服用1次,每次服用10ml~50ml。
本发明提供的组合物中各组分均为天然产物,避免了人工合成物质所带来的副作用。组合物中各成分相互配合时,各成分具有协同作用,能够增强组合物的功效。组合物同时具有清肺润肺、增强免疫力的功效,疗效显著。而且本发明不易产生耐药性,无毒副作用和不良反应。
以下结合实施例对本发明的特征和性能作进一步的详细描述。
实施例一
一种清肺润肺、增强免疫力的组合物,其原料按重量份数计包括:益生菌酵素1800份、亚麻籽粉3份、雨生红球藻粉1份、茶籽粉1份、库拉索芦荟粉1份、蘑菇粉1份、黑木耳粉1份、青钱柳叶1份、果蔬纤维素10份、枸杞1份、人参1份、大枣1份、玛卡粉1份、低聚果糖2份、白果叶粉1份、雪梨汁10份、枇杷10份、枇杷叶1份、枇杷树皮1份、罗汉果1份和胖大海1份。
将上述原料按配比混合,并按照常规制口服液的方法制成口服液。
实施例二
一种清肺润肺、增强免疫力的组合物,其原料按重量份数计包括:益生菌酵素2500份、亚麻籽粉10份、雨生红球藻粉7份、茶籽粉7份、库拉索芦荟粉7份、蘑菇粉7份、黑木耳粉7份、青钱柳叶7份、果蔬纤维素20份、枸杞7份、人参7份、大枣7份、玛卡粉7份、低聚果糖3份、白果叶粉7份、雪梨汁20份、枇杷20份、枇杷叶7份、枇杷树皮7份、罗汉果7份、胖大海7份、牡丹籽粉7份、磷虾粉7份、DHA藻油7份、白果粉7份。
将上述原料按配比混合,并按照常规制口服液的方法制成口服液。
实施例三
一种清肺润肺、增强免疫力的组合物,其原料按重量份数计包括:益生菌酵素为2000份、亚麻籽粉为5份、雨生红球藻粉为3份、茶籽粉为3份、库拉索芦荟粉为3份、蘑菇粉为3份、黑木耳粉为3份、青钱柳叶为3份、果蔬纤维素为10份、枸杞为2份、人参为2份、大枣为3份、玛卡粉为3份、低聚果糖为2份、白果叶粉3份、雪梨汁10份、枇杷10份、枇杷叶3份、枇杷树皮3份、罗汉果3份、胖大海3份、牡丹籽粉为3份、磷虾粉为3份、DHA藻油为3份、白果粉为3份、维生素B1为1份、维生素B2为1份、维生素B6为1份、维生素B12为1份、维生素C为2份、维生素D3为0.5份。
将上述原料按配比混合,并按照常规制口服液的方法制成口服液。
实施例四
一种清肺润肺、增强免疫力的组合物,其原料按重量份数计包括:益生菌酵素2000份、亚麻籽粉7份、雨生红球藻粉5份、茶籽粉5份、库拉索芦荟粉5份、蘑菇粉5份、黑木耳粉5份、青钱柳叶5份、果蔬纤维素15份、枸杞5份、人参5份、大枣5份、玛卡粉5份、低聚果糖3份、白果叶粉5份、雪梨汁15份、枇杷15份、枇杷叶5份、枇杷树皮5份、罗汉果5份、胖大海5份、牡丹籽粉1份、磷虾粉1份、DHA藻油1份、白果粉1份。
将上述原料按配比混合,并按照常规制片剂的方法制成片剂。
实施例五
一种清肺润肺、增强免疫力的组合物,其原料按重量份数计包括:益生菌酵素2200份、亚麻籽粉6份、雨生红球藻粉4份、茶籽粉4份、库拉索芦荟粉4份、蘑菇粉4份、黑木耳粉4份、青钱柳叶4份、果蔬纤维素12份、枸杞3份、人参3份、大枣4份、玛卡粉4份、低聚果糖2份、白果叶粉4份、雪梨汁4份、枇杷4份、枇杷叶4份、枇杷树皮4份、罗汉果4份、胖大海4份、牡丹籽粉5份、磷虾粉5份、DHA藻油5份、白果粉5份。
将上述原料按配比混合,并按照常规制粉的方法制成粉末。
实施例六
一种清肺润肺、增强免疫力的组合物,其原料按重量份数计包括:益生菌酵素2300份、亚麻籽粉8份、雨生红球藻粉6份、茶籽粉6份、库拉索芦荟粉6份、蘑菇粉6份、黑木耳粉6份、青钱柳叶6份、果蔬纤维素14份、枸杞5份、人参5份、大枣6份、玛卡粉6份、低聚果糖3份、白果叶粉4份、雪梨汁12份、枇杷12份、枇杷叶4份、枇杷树皮4份、罗汉果4份、胖大海4份、牡丹籽粉6份、磷虾粉6份、DHA藻油6份、白果粉6份。
试验例
供试样品:由本发明实施例一、实施例二和实施例三的组方制成的口服液。
(1)实验动物:
刚断乳的雄性Wistar大鼠,50只,由济南大学试验动物中心提供,饲养于动物试验中心。
(3)分组及处理方法:
将大鼠随机分为5组,每组10只。
空白对照组:灌胃等溶剂生理盐水,连续2个月。
肺气对照组:灌胃等溶剂生理盐水,连续2个月。
治疗1组:将实施例一制备的功能性食品的口服液以0.6g/100g的剂量,连续灌胃2个月。
治疗2组:将实施例二制备的功能性食品的口服液以0.6g/100g的剂量,连续灌胃2个月。
治疗3组:将实施例三制备的功能性食品的口服液以0.6g/100g的剂量,连续灌胃2个月。
(2)肺气虚动物模型的制作
将肺气对照组、治疗1组、治疗2组和治疗3组分别采用烟熏法复制模型:即将大鼠置烟熏箱内,用10支滤嘴香烟和50g锯末一起点燃后烟熏30min,每日1次。连续处理30天,其间大鼠自由进食进水,空白对照组大鼠置于无烟环境中喂养。
(3)实验内容和结果
各组大鼠按体重以2%戊巴比妥钠0.3ml/100g腹腔内麻醉,约3~5min后于颈部正中行气管切开,并检测所需肺功能的各项指标,包括气道阻力(Ri)、动态肺顺应性(Cdyn)、肺活量(VC)、肺总量(TLC)等。
与正常组大鼠比较,肺气对照组大鼠Ri增加,Cdyn明显降低,VC明显减少,TLC减少。
实验结果表明,供试样品能改善肺气虚大鼠气喘,呼吸不畅等症状,降低吸气阻力、增加动态肺顺应性、肺活量以及肺总量。以上结果均提示该供试品有改善肺气虚大鼠呼吸功能的作用。
以上所描述的实施例是本发明一部分实施例,而不是全部的实施例。本发明的实施例的详细描述并非旨在限制要求保护的本发明的范围,而是仅仅表示本发明的选定实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
Claims (10)
1.一种清肺润肺、增强免疫力的组合物,其特征在于,其原料按重量份数计包括:益生菌酵素1800~2500份、亚麻籽粉3~10份、雨生红球藻粉1~7份、茶籽粉1~7份、库拉索芦荟粉1~7份、蘑菇粉1~7份、黑木耳粉1~7份、青钱柳叶1~7份、果蔬纤维素10~20份、枸杞1~7份、人参1~7份、大枣1~7份、玛卡粉1~7份、低聚果糖2~3份、白果叶粉1~7份、雪梨汁10~20份、枇杷10~20份、枇杷叶1~7份、枇杷树皮1~7份、罗汉果1~7份和胖大海1~7份。
2.根据权利要求1所述的清肺润肺、增强免疫力的组合物,其特征在于,按重量份数计,所述原料包括所述益生菌酵素2000份、所述亚麻籽粉5~7份、所述雨生红球藻粉3~5份、所述茶籽粉3~5份、所述库拉索芦荟粉3~5份、所述蘑菇粉3~5份、所述黑木耳粉3~5份、所述青钱柳叶3~5份、所述果蔬纤维素10~15份、所述枸杞2~5份、所述人参2~5份、所述大枣3~5份、所述玛卡粉3~5份、所述低聚果糖2~3份、所述白果叶粉3~5份、所述雪梨汁10~15份、所述枇杷10~15份、所述枇杷叶3~5份、所述枇杷树皮3~5份、所述罗汉果3~5份和所述胖大海3~5份。
3.根据权利要求1所述的清肺润肺、增强免疫力的组合物,其特征在于,按重量份数计,所述原料还包括牡丹籽粉1~7份、磷虾粉1~7份、DHA藻油1~7份、白果粉1~7份。
4.根据权利要求3所述的清肺润肺、增强免疫力的组合物,其特征在于,按重量份数计,所述原料包括所述牡丹籽粉3~5份、所述磷虾粉3~5份、所述DHA藻油3~5份、所述白果粉3~5份。
5.根据权利要求3所述的清肺润肺、增强免疫力的组合物,其特征在于,所述原料还包括维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D3。
6.根据权利要求1所述的清肺润肺、增强免疫力的组合物,其特征在于,所述果蔬纤维素包括苹果纤维、香蕉纤维、菠萝纤维、红枣纤维、芹菜纤维以及胡萝卜纤维。
7.根据权利要求1所述的清肺润肺、增强免疫力的组合物,其特征在于,所述益生菌酵素主要由复配益生菌在益生菌培养基上培养发酵制得,按重量份数计,所述复配益生菌包括:青春双歧杆菌20~100份、嗜酸乳杆菌20~100份、嗜热乳杆菌20~100份、短双歧杆菌20~100份、双歧杆菌20~100份、植物乳杆菌20~100份。
8.根据权利要求7所述的清肺润肺、增强免疫力的组合物,其特征在于,所述益生菌培养基包括:菌类多糖、藻类多糖、植物粉、花粉、水果、蔬菜和五谷。
9.根据权利要求1~8任意一项所述的组合物在制备清肺润肺、增强免疫力药物中的应用。
10.根据权利要求1~8任意一项所述的组合物在制备清肺润肺、增强免疫力食品中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610814988.4A CN106389784A (zh) | 2016-09-09 | 2016-09-09 | 清肺润肺、增强免疫力的组合物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610814988.4A CN106389784A (zh) | 2016-09-09 | 2016-09-09 | 清肺润肺、增强免疫力的组合物及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106389784A true CN106389784A (zh) | 2017-02-15 |
Family
ID=57999209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610814988.4A Pending CN106389784A (zh) | 2016-09-09 | 2016-09-09 | 清肺润肺、增强免疫力的组合物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106389784A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106889610A (zh) * | 2017-02-22 | 2017-06-27 | 钱凤英 | 一种芦荟山楂酵素及其制作方法 |
US10973779B2 (en) * | 2019-03-14 | 2021-04-13 | Bioptik Technology, Inc. | Astaxanthin compound composition and the method thereof |
US11020445B2 (en) | 2017-11-08 | 2021-06-01 | Tci Co., Ltd. | Method for reducing the content of heavy metals in blood and improving the pulmonary function using green pear fruitlet extract |
CN114164141A (zh) * | 2021-10-29 | 2022-03-11 | 北京亿康倍尔生物科技有限公司 | 增强肺部功能的益生菌组合物及其制剂和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103181563A (zh) * | 2012-10-28 | 2013-07-03 | 赵言林 | 黑木耳玛卡(maca)复方 |
CN103815407A (zh) * | 2014-03-14 | 2014-05-28 | 苏州科大微龙信息技术有限公司 | 一种调理痰湿体质酵素及其制备方法 |
CN104667135A (zh) * | 2015-03-19 | 2015-06-03 | 海南大学 | 一种药物组合物、保健品及制备方法 |
CN105249102A (zh) * | 2015-10-25 | 2016-01-20 | 宁静 | 一种提高免疫力的保健醋饮 |
-
2016
- 2016-09-09 CN CN201610814988.4A patent/CN106389784A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103181563A (zh) * | 2012-10-28 | 2013-07-03 | 赵言林 | 黑木耳玛卡(maca)复方 |
CN103815407A (zh) * | 2014-03-14 | 2014-05-28 | 苏州科大微龙信息技术有限公司 | 一种调理痰湿体质酵素及其制备方法 |
CN104667135A (zh) * | 2015-03-19 | 2015-06-03 | 海南大学 | 一种药物组合物、保健品及制备方法 |
CN105249102A (zh) * | 2015-10-25 | 2016-01-20 | 宁静 | 一种提高免疫力的保健醋饮 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106889610A (zh) * | 2017-02-22 | 2017-06-27 | 钱凤英 | 一种芦荟山楂酵素及其制作方法 |
US11020445B2 (en) | 2017-11-08 | 2021-06-01 | Tci Co., Ltd. | Method for reducing the content of heavy metals in blood and improving the pulmonary function using green pear fruitlet extract |
TWI740071B (zh) * | 2017-11-08 | 2021-09-21 | 大江生醫股份有限公司 | 青梨早摘果萃取物用於降低血液中重金屬及提升肺功能的用途 |
US10973779B2 (en) * | 2019-03-14 | 2021-04-13 | Bioptik Technology, Inc. | Astaxanthin compound composition and the method thereof |
CN114164141A (zh) * | 2021-10-29 | 2022-03-11 | 北京亿康倍尔生物科技有限公司 | 增强肺部功能的益生菌组合物及其制剂和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104824548B (zh) | 枸杞复合保健酵素及其制备方法 | |
CN103190626B (zh) | 治疗口腔溃疡的果蔬食品及其制备方法 | |
CN103027231B (zh) | 一种复合益生菌发酵中草药活性保健液及其制备方法 | |
CN106954847A (zh) | 具有润肠通便功能的酵素益生菌组合物、应用及加工制剂 | |
KR101646156B1 (ko) | 숙변 제거 효능이 있는 장 기능 개선 발효식품 및 그 제조방법 | |
CN107048409A (zh) | 制备具有调理失眠多梦改善睡眠功效的植物酵素的发酵组合物及制法 | |
KR20180037693A (ko) | 폐질환 예방 및 개선을 위한 식품 조성물 | |
CN109480281A (zh) | 一种有机黑果枸杞酵素及其制备方法 | |
CN106389784A (zh) | 清肺润肺、增强免疫力的组合物及其应用 | |
CN103766904A (zh) | 一种具有降脂、通便功能胶囊的制备及其应用 | |
CN112569323A (zh) | 一种解酒护肝的组合物及其应用 | |
CN104305207A (zh) | 一种中药复合酵素的配方及其制备方法 | |
CN106858579A (zh) | 制备适用于糖尿病调理及日常养护的植物酵素的发酵组合物及制法 | |
CN111493273B (zh) | 一种滇黄精发酵液制备方法 | |
CN106858215A (zh) | 一种百香果复合饮料 | |
CN106858577A (zh) | 制备具有保肝护肝、调节脂肪肝代谢功能的植物酵素的发酵组合物及制法 | |
CN104667135A (zh) | 一种药物组合物、保健品及制备方法 | |
CN105125997A (zh) | 一种解酒茶及其制备方法 | |
CN102919956B (zh) | 调理人体消化系统的营养液及其制备方法 | |
CN106983146A (zh) | 制备具有调理和增强人体排毒养颜功效的植物酵素的发酵组合物及制法 | |
CN106880040A (zh) | 制备具有适用于风湿骨关节病人调理养护的植物酵素的发酵组合物及制法 | |
KR20180000874A (ko) | 미세먼지 및 중금속과 항생물질 분해 배출에 도움을 주는 영양식품 조성물 및 이를 제조하는 방법 | |
CN115486541B (zh) | 一种具有美白功效的草本益生菌组合物及其制备方法 | |
CN105497106A (zh) | 一种中药复合发酵粉及其制备方法 | |
KR102165106B1 (ko) | 황칠 추출물이 함유된 변비 질환 개선용 환제 또는 과립제 및 그 제조방법. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170215 |